Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Mogamulizumab can cause hair loss and skin rashes.

Dermal EZH2 controls skin cell growth and differentiation in mice.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

BST2 protein and certain T cells increase in early alopecia areata.

Onychomatricoma is a unique nail tumor, not related to other hair-related tumors.

A married couple both developed alopecia areata, possibly due to shared stress.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Bcl-2 affects hair growth and pigmentation by controlling cell death.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Dermal EZH2 controls skin cell development and hair growth in mice.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.

AIMP1 can boost hair growth by increasing stem cell activity.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

Topical rapamycin may effectively treat fibrous papules on the face.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.